dr martins nutrition l carnitine Dr. Martin's Extra Strength L-carnitine - 200 C L-Carnitine in the Treatment of

the pharmaceutically acceptable carrier preferably is a lipoplex system comprising at least one of cationic lipids or amphoteric lipids (as detailed in WO2002/066012 ), or a polyplex system comprising at least one of poly-L-Lysine, poly-L-ornithine, polyethyleneimine, and polyamidoamine

Under normal mitochondrial homeostasis, anti-apoptotic members of the BCL-2 family, such as BCL-2 and BCL-xL, are anchored in the outer mitochondrial membrane

The experiment was conducted in three independent series, with at least three repetitions of each result ( n = 3)

S., Georgopoulos P., Sonnewald U., Plaitakis A., and Schousboe A